Whitepaper
22 Sep 2021

Novel, ready-to-fill capsules with gastric resistant functionality for fast, high-performance drug development

PDF 2.1 MB

Developing a delayed release formulation of acid-sensitive actives that can be used in solid dosage forms such as tablets, pellets and capsules can be costly. Usually several stages are involved starting from R&D development to scale up and validation steps, all of which require significant investment of time and money. Sourcing a ready-to-fill functional capsule is an effective way of saving costs, reducing time to market, and boosting the performance of oral drug delivery products. EUDRACAP is our recently launched non-animal-derived platform of functional, ready-to-fill capsules for fast-track development of sensitive drugs.

Content provided by our supplier

Evonik Industries AG

  • DE
  • 2015
    On CPhI since
  • 4
    Certificates
  • 5000+
    Employees
Manufacturer/Innovator

Other Content from Evonik Industries AG